You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Racing to a Cure is not a cancer memoir. It is a cancer cure memoir. In 1998 Neil Ruzic was diagnosed with mantle-cell lymphoma, the deadliest cancer of the lymph system, whose spread is reaching epidemic levels in the U.S. and Europe. Instead of following recommended courses of chemotherapy and radiation, he took control of his treatment by investigating cures being developed in the nation's cancer-research laboratories. Although chemotherapy harms the immune system and is increasingly demonstrated to be an ineffective long-term cure for the vast majority of cancers, it remains the standard treatment for most cancer patients. Ruzic, a former scientific magazine publisher and originator of a...
First multi-year cumulation covers six years: 1965-70.
Hematology and Oncology – as only Harrison’s can cover it Featuring a superb compilation of chapters on hematology and oncology that appear in Harrison’s Principles of Internal Medicine, Eighteenth Edition, this concise, full-color clinical companion delivers the latest knowledge in the field backed by the scientific rigor and authority that have defined Harrison’s. You will find content from renowned editors and contributors in a carry-anywhere presentation that is ideal for the classroom, clinic, ward, or exam/certification preparation. Features Organized into twelve sections: The Cellular Basis of Hematopoiesis; Cardinal Manifestations of Hematologic Diseases; Anemias, Myeloprolif...
None
"An engrossing exposé of scientific practice in America.” —KIRKUS REVIEWS From the authors of the New York Times bestselling Plague of Corruption comes the prescription on how to end the plague infecting our medical community. Ending Plague continues the New York Times bestselling team of Dr. Judy A. Mikovits and Kent Heckenlively with legendary scientist, Dr. Francis W. Ruscetti joining the conversation. Dr. Ruscetti is credited as one of the founding fathers of human retrovirology. In 1980, Dr. Ruscetti’s team isolated the first pathogenic human retrovirus, HTLV-1. Ruscetti would eventually go on to work for thirty-eight years at the National Cancer Institute. Dr. Ruscetti was deepl...
None